The Chemical Transmission at the Neuromuscular Junction Experiment – Henry Dale

The history of neuroscience is punctuated by moments of intense conceptual crisis, wherein prevailing physical doctrines collide with emerging biochemical realities. At the turn of the twentieth century, the fundamental nature of intercellular communication within the nervous system stood as one of biology’s most fiercely contested enigmas. While the pioneering anatomical investigations of Santiago Ramón y Cajal had established the neuron doctrine—demonstrating that nervous tissue is composed of discrete, individualized cellular units rather than a continuous, syncytial reticulum—the mechanism whereby an impulse bridges the physical gap separating an axon terminal from an effector cell remained completely unresolved. This physical discontinuity, christened the “synapse” by Sir Michael Foster and Charles Sherrington, presented a profound biophysical paradox: how could an electrical impulse traverse a non-conducting fluid barrier with the microsecond velocity demanded by somatic reflexes?

For decades, the dominant electrophysiological establishment championed the concept of direct electrical transmission. This school of thought, later colloquially termed the doctrine of the “Sparks,” maintained that the action potential swept continuously across the synaptic chasm through local electrical circuits, activating the post-junctional membrane via immediate capacitive coupling. Opposing this view was a minority coalition of pharmacologists and biochemists—the advocates of the “Soups”—who posited that the nerve terminal operates as an ultra-specialized secretory organ, discharging minute quantities of a specific chemical mediator capable of diffusing across the cleft to activate specialized receptors on the target tissue. The debate over this mechanism was not merely semantic; it pitted the biophysical reductionism of classical electrophysiology against the dynamic macromolecular paradigms of modern chemical pharmacology.

The definitive resolution of this controversy within the voluntary motor system represents one of the crowning achievements of twentieth-century physiology. Orchestrated by Sir Henry Hallett Dale alongside his brilliant collaborators Wilhelm Feldberg and Marthe Vogt at the National Institute for Medical Research in Hampstead, a series of experimental investigations conducted between 1934 and 1936 shattered the electrical hegemony. By systematically demonstrating that the stimulation of voluntary motor nerves elicits the physiological release of acetylcholine at the skeletal neuromuscular junction, Dale and his colleagues bridged the conceptual chasm between the vegetative autonomic system and the somatic motor system. Their meticulously executed perfusion protocols, sensitive biological assays, and pharmacological replications transformed our understanding of synaptic transmission, inaugurating modern neurochemistry and reshaping clinical medicine.

1. Introduction to the Paradigm Shift: From Electrical Sparks to Chemical Messengers

The conceptual transition from electrical conduction to neurohumoral transmission required dismantling centuries of physiological dogma regarding the physical nature of neuromuscular excitation. Before chemical messengers could be accepted as the mediators of voluntary action, the prevailing paradigms of bioelectricity had to be subjected to rigorous empirical critique.

1.1 The Pre-Twentieth Century Understanding of Nerve-Muscle Communication

The earliest physiological inquiries into voluntary motion were dominated by mechanical and pneumatic doctrines that traced their intellectual lineage to Galen of Pergamon. For over a millennium, natural philosophers conceptualized nerves as hollow conduits charged with conveying “animal spirits”—an imponderable, subtle vapor distilled within the cerebral ventricles—into the muscle belly. Upon arrival, this ethereal substance was presumed to physically distend the muscular fibers, generating swelling that produced mechanical shortening. This hydraulic model persisted until the late eighteenth century, when the pioneering experiments of Luigi Galvani and Alessandro Volta fundamentally altered the conceptual landscape. Galvani’s discovery of “animal electricity” demonstrated that direct electrical stimulation of the isolated crural nerve could provoke violent contractions in the detached hindlimb of a frog, effectively banishing animal spirits in favor of galvanic phenomena.

Throughout the nineteenth century, the physicalist school of German physiology, spearheaded by Emil du Bois-Reymond, Hermann von Helmholtz, and Carl Ludwig, sought to reduce all vital manifestations to measurable physical forces. Helmholtz’s landmark quantification of the velocity of the nervous impulse in 1850 demonstrated that conduction along a peripheral nerve was not instantaneous, as Johannes Müller had fatalistically declared, but proceeded at a measurable, modest speed of roughly twenty-seven to thirty meters per second. This finding solidified the conviction that nerve impulses were intrinsic biophysical events governed by longitudinal wave-like alterations in membrane electrical polarization. Du Bois-Reymond’s developing concepts of electrophysiology led him, in his prophetic 1877 treatise, to explicitly formulate two alternative theoretical models for transmission at the motor endplate: either the electrical action current of the axon directly excites the sarcoplasm through local current circuits, or the axonal terminal liberates an ultra-potent stimulating substance that excites the muscle chemically. Despite du Bois-Reymond’s remarkably modern agnosticism, the physiological consensus overwhelmingly rallied around the former hypothesis.

The technological apparatus available to nineteenth-century electrophysiologists reinforced this bias toward direct electrical excitation. Investigators relied upon instruments such as the capillary electrometer, the rheotome, and early mirror galvanometers. While these tools were sufficient to detect slow, macroscopic changes in tissue polarization, they suffered from crippling mechanical inertia and lacked the requisite high-frequency responsiveness to record millisecond-scale potential deflections accurately. Because electrical currents were readily measurable along both nerve trunks and muscle membranes, and because an electric shock delivered directly to the motor nerve reliably caused instantaneous contraction, it seemed parsimonious to conclude that transmission across the junction was fundamentally an uninterrupted electrical propagation. Any theoretical invocation of chemical intermediates was widely dismissed as an unnecessary complication that could not reconcile the lightning-fast speed of voluntary neuromuscular reflexes with the comparatively sluggish kinetics of chemical diffusion.

1.2 The Emergence of Chemical Theories of Synaptic Action

The dawn of the twentieth century witnessed the earliest cracks in the purely electrical framework, emerging not from electrophysiology, but from analytical pharmacology and receptor theory. At the University of Cambridge, John Newport Langley conducted exhaustive investigations into the actions of exogenous alkaloids upon glandular and muscular targets. In his landmark 1905 paper on the reaction of cells and nerve-endings to certain substances, Langley observed that nicotine applied locally to skeletal muscle produced prolonged, localized contractures. Crucially, Langley demonstrated that this contracture occurred even after the motor nerve had been transected and allowed to degenerate completely, eliminating any viable anatomical nerve terminal. When he applied curare, the nicotine-induced contraction was selectively abolished, yet the muscle remained directly responsive to direct electrical stimulation.

From these rigorous observations, Langley deduced that the site of action for these pharmacological agents was neither the axon terminal nor the contractile machinery of the sarcoplasm itself. Instead, he formulated the revolutionary concept of the “receptive substance”—a specialized, chemically distinct receptive entity situated at the junctional region of the muscle cell membrane. Langley asserted that this receptive substance was capable of binding specific chemical ligands, which in turn altered the physiological functional state of the effector organ. Almost simultaneously, in Frankfurt, Paul Ehrlich was developing his side-chain theory of antibody-antigen interactions and chemotherapeutic targeting, crystallizing the universal pharmacological axiom: Corpora non agunt nisi fixata (“substances do not act unless bound”). Ehrlich’s mathematical and structural models of receptor-ligand pairing provided a robust conceptual scaffold for Langley’s physiological postulations.

Concurrently, early pharmacologists were documenting the remarkable biological actions of tissue extracts and organic alkaloids upon autonomic visceral targets. In 1904, Langley’s student, Thomas Renton Elliott, noted the striking parallelism between the physiological effects elicited by electrical stimulation of the sympathetic nervous system and the responses evoked by the application of extracts from the adrenal medulla (adrenaline). Elliott famously speculated that sympathetic nerve impulses might act by liberating microscopic quantities of an adrenaline-like chemical at their peripheral destinations. However, the conceptual hurdle of extending such chemical transmission models to skeletal muscle remained formidable. Skeletal muscle contractions operate on a timescale of milliseconds, requiring rapid twitches, tetanic fusion, and immediate relaxation. Biological diffusion of chemical solutes was universally regarded as an inherently slow, thermally governed passive process, seemingly incapable of facilitating the rapid, high-frequency synchronization observed during somatic motor execution.

1.3 The Core Thesis of Henry Dale’s Neuromuscular Research

The overarching intellectual mission of Sir Henry Hallett Dale’s career was to establish neurohumoral chemical mediation as a fundamental, universal biological law governing both autonomic and somatic divisions of the nervous system. While the seminal discoveries of Otto Loewi in 1921 had provided compelling evidence that humoral substances mediate the slow, regulatory actions of the autonomic vagus nerve on the amphibian myocardium, the electrophysiological community adamantly maintained that such mechanisms were restricted to vegetative, involuntary, and sluggishly reacting tissues. Skeletal muscle, with its highly differentiated motor endplates, rapid motor unit recruitment, and instantaneous refractory recovery, was stubbornly defended as an inviolable sanctuary of pure electrical conduction.

Dale rejected this fundamental physiological bifurcation. His core thesis posited that the structural discontinuity exposed by the neuron doctrine applied equally to the somatic neuromuscular endplate, and that nature had not invented two diametrically opposed biophysical architectures to solve identical physiological problems. Dale asserted that voluntary motor nerve stimulation must inevitably release a specific, endogenous chemical mediator from the presynaptic axonal arborization into the sub-microscopic synaptic cleft. Furthermore, he insisted that this substance was none other than acetylcholine—an ester whose extraordinary potency and fleeting duration of biological action uniquely suited it for high-frequency transmission.

To establish this hypothesis beyond empirical reproach, Dale formulated rigorous epistemological criteria. He recognized that it was not enough to merely demonstrate that exogenous acetylcholine could mimic motor nerve stimulation, nor was it sufficient to detect traces of the ester within whole muscle extracts after sustained muscular activity. Dale understood that he had to definitively establish four interdependent physiological benchmarks:
First, the chemical mediator must be demonstrably released into the extracellular fluid strictly as a consequence of physiological motor nerve stimulation.
Second, this release must be presynaptic in origin, occurring independently of the secondary mechanical or electrical events associated with muscle contraction.
Third, the spatial and temporal application of the exogenous chemical to the junctional region must faithfully reproduce the precise mechanical and electrical kinetics of a physiological nerve impulse.
Fourth, an exquisitely rapid and localized enzymatic inactivation mechanism must be present at the site of transmission to terminate the biological action of the transmitter within the fraction of a millisecond demanded by the absolute refractory period of skeletal muscle.

2. Historical Foundations: The Pharmacological Characterization of Acetylcholine

Before acetylcholine could be recognized as the natural transmitter of voluntary motor impulses, it had to be discovered, synthesized, pharmacologically classified, and authenticated as a genuine endogenous constituent of mammalian tissue. This process occupied more than two decades of rigorous chemical and pharmacological exploration.

2.1 Dale’s Early Work at the Wellcome Physiological Research Laboratories

The entry of Henry Dale into the study of choline esters was entirely serendipitous, originating in the commercial and pharmacological examination of ergot (Claviceps purpurea), a fungal parasite of rye grass. In 1904, Dale accepted a position at the Wellcome Physiological Research Laboratories in Herne Hill, an industrial institute directed by pharmaceutical entrepreneur Henry Wellcome. While standardizing extracts of ergot intended for obstetrical use, Dale noted that certain preparations exhibited strange, anomalous physiological activities that could not be attributed to known ergot alkaloids such as ergotoxine or histamine. These anomalous extracts provoked profound, transient depressions in arterial blood pressure, accompanied by marked bradycardia and vigorous salivation in experimental animals.

Dale joined forces with the talented organic chemist Arthur James Ewins to isolate the elusive active principle from these ergot extracts. By 1914, Ewins had successfully isolated and chemically characterized the compound as acetylcholine (the acetic acid ester of the quaternary ammonium base choline). Acetylcholine itself was not a completely novel chemical; it had been chemically synthesized in 1867 by the German chemist Adolf von Baeyer, who referred to it simply as acetylcholin, and later synthesized by Reid Hunt and René de M. Taveau in 1906 during investigations into the vasodepressor properties of choline derivatives. Hunt and Taveau had documented that acetylcholine was astonishingly active—exhibiting a vasodepressor potency roughly 100,000 times greater than that of unesterified choline.

When Dale systematically injected Ewins’ synthetic acetylcholine into mammalian test preparations, he was transfixed by its biological profile. It possessed an almost instantaneous onset of action, but its biological effects vanished with comparable rapidity. Even massive intravenous doses elicited responses that subsided within seconds, a phenomenon Dale recognized as fundamentally distinct from the enduring actions of most classical alkaloids. Dale immediately reasoned that such evanescent potency could only be explained if the living tissues of the body harbored an extraordinarily efficient, specialized catalytic mechanism. In his foundational 1914 paper, Dale formally advanced the enzymatic degradation hypothesis, postulating the universal presence in blood and tissues of an endogenous, highly active esterase that rapidly hydrolyzes acetylcholine into its biologically inert components: free choline and acetic acid.

2.2 Delineation of Muscarinic and Nicotinic Actions

In his monumental 1914 communication titled “The action of certain esters and ethers of choline, and their relation to muscarine,” published in the Journal of Pharmacology and Experimental Therapeutics, Dale constructed the pharmacological taxonomy that continues to govern modern neuropharmacology. Dale observed that the protean biological actions of acetylcholine could not be treated as a single, uniform phenomenon; rather, its effects fell into two distinct, fundamentally separable physiological categories, which he categorized based on their pharmacological mimicry by specific plant alkaloids: muscarine and nicotine.

The first category of actions, which Dale designated as the muscarinic actions, comprised those biological responses that mimicked the postganglionic parasympathetic stimulation of visceral and vegetative organs. These included intense slowing of the heart rate (negative chronotropy) and reduction in contractile force (negative inotropy); vasodilation of peripheral vascular beds with a profound fall in systemic arterial pressure; constriction of the bronchioles; increased tone and motility of the gastrointestinal smooth musculature; and profuse secretion from exocrine structures, including the salivary, lachrymal, and sweat glands. Dale demonstrated that all of these muscarinic manifestations could be selectively and completely abolished by the application of the solanaceous alkaloid atropine, leaving other physiological systems entirely unimpaired.

The second category of actions, which Dale classified as the nicotinic actions, emerged with striking clarity once the muscarinic responses had been neutralized by atropine. If an atropinized animal was administered a larger dose of acetylcholine, the cardiovascular depression and glandular hypersecretion failed to appear. Instead, there emerged a dramatic, secondary rise in arterial blood pressure, driven by the stimulation of sympathetic autonomic ganglia and the release of adrenaline from the chromaffin cells of the suprarenal medulla. Furthermore, Dale documented that this atropine-resistant acetylcholine component elicited rapid, fasciculatory contractions and sustained spasms of voluntary skeletal muscle. These responses closely mimicked the primary excitant actions of nicotine upon autonomic ganglion cells and somatic motor endplates. Dale showed that this nicotinic response was selectively antagonized by large doses of curare, thus providing the critical pharmacological wedge required to isolate and investigate the putative chemical receptive properties of the somatic neuromuscular junction.

2.3 Identification of Endogenous Acetylcholine in Mammalian Tissue

Despite the pharmacological precision of Dale’s 1914 synthesis, a severe epistemological critique stalled the acceptance of acetylcholine as a physiological entity: there was no definitive proof that acetylcholine existed naturally within the mammalian organism. Until the late 1920s, skeptics dismissed acetylcholine as a “pharmacological curiosity”—a synthetic or botanical artifact that happened to display extraordinary potency when injected into an animal, but one that played no physiological role in normal biology. The primary barrier preventing its physical isolation from animal tissues was precisely its biological evanescence: any attempt to grind, homogenize, or extract mammalian organs led to instantaneous enzymatic destruction of the native ester by the very esterases Dale had theorized.

The definitive breakthrough came in 1929 through a tour de force of biochemical extraction conducted by Henry Dale and the chemist Harold Ward Dudley. Recognizing that previous isolation attempts had failed due to post-mortem enzymatic hydrolysis, Dale and Dudley designed an extraction protocol specifically engineered to denature tissue enzymes instantly. They procured fresh equine spleens directly from the slaughterhouse, plunging the sliced tissue immediately into ice-cold acidified alcohol to precipitate the endogenous proteins and permanently inactivate all hydrolytic enzymes.

Through exhaustive fractionations, crystallizations, and chemical derivatizations, Dale and Dudley successfully isolated pure, crystalline choline esters from the spleen extract. They synthesized the platinum double chloride and chloroplatinate salts of the isolated substance, demonstrating that its crystalline structure, melting point, and elementary chemical composition were indistinguishable from pure synthetic acetylcholine. Crucially, they verified their biochemical yield via parallel biological assays on blood pressure and isolated smooth muscle strips, confirming that the isolated endogenous substance possessed the precise quantitative biological potency expected of acetylcholine. The 1929 Dale and Dudley paper permanently silenced the objection that acetylcholine was merely an artificial drug, establishing beyond doubt that it was an authenticated endogenous molecule produced, stored, and concentrated within mammalian parenchymal tissues.

3. The ‘Soups vs. Sparks’ Controversy: The Intellectual Battleground

The scientific decade from 1925 to 1936 was marked by the legendary intellectual clash between neurophysiologists and pharmacologists over the physical basis of synaptic transmission. This ideological confrontation, widely remembered as the “Soups vs. Sparks” controversy, polarized the scientific community and drove both camps toward technical and theoretical innovations.

3.1 The Electrical Doctrine Defended by John Carew Eccles

The intellectual vanguard of the electrical doctrine was commanded by the young Australian neurophysiologist John Carew Eccles, a devoted disciple of Sir Charles Sherrington at Oxford. Eccles, armed with the latest advances in high-vacuum cathode-ray oscillography and low-distortion vacuum tube amplifiers, approached the synapse from a framework grounded strictly in mathematical physics and circuit theory. To Eccles, the primary, insurmountable vulnerability of the chemical transmission hypothesis was the extreme temporal brevity of the synaptic delay.

When an action potential arrives at the nerve terminal of a skeletal muscle fiber, the subsequent excitation of the muscle membrane occurs after an infinitesimally brief latency—measured by early twentieth-century biophysicists as between 0.5 and 1.5 milliseconds. Eccles argued passionately that it was physically impossible for a chemical substance to be synthesized or mobilized from storage, secreted across the presynaptic membrane, diffuse across the intervening synaptic cleft, bind to post-junctional receptors, and initiate an action potential within that brief fraction of a millisecond. Chemical diffusion, he maintained, was a non-linear process governed by Fick’s laws, inherently subject to thermal dissipation, viscous drag, and spatial dilution.

Instead, Eccles formulated an elegant physical model: when the electrical action current depolarizing the presynaptic nerve terminal reaches the non-conducting gap of the synapse, it generates localized, high-density electrical “eddy currents” in the extracellular fluid. These action currents, streaming into the pre-synaptic arborization, must exit across the synaptic cleft, flowing across the muscle endplate membrane to complete the electrical circuit. Eccles asserted that these intense, localized currents directly altered the membrane potential of the motor endplate, triggering self-propagating action potentials in the muscle fiber through immediate electrical induction. The electrophysiologists looked with profound skepticism upon the pharmacological experiments of Dale, viewing the crude injection of pharmacological substances into circulating blood as an unphysiological artifact that bore no resemblance to the microscopic, localized events occurring within intact, uninjured tissue.

3.2 The Chemical Doctrine Advanced by Henry Dale and Otto Loewi

The foundation of the modern chemical doctrine was established experimentally in Graz, Austria, by Otto Loewi in 1921. In his immortal Vagusstoff experiment, Loewi cannulated the heart of a frog, leaving the vagus nerve intact, and filled the ventricular chamber with physiological Ringer’s solution. Upon electrical stimulation of the vagus nerve, the heart slowed and weakened. Loewi then aspirated the fluid from this donor heart and transferred it into a second, completely denervated frog heart. Astonishingly, the recipient heart immediately exhibited identical bradycardia and inotropic depression, demonstrating unequivocally that the vagus nerve had liberated a soluble, diffusible chemical mediator into the perfusion fluid. Shortly thereafter, Loewi demonstrated that stimulation of the sympathetic accelerans nerves released a distinct substance that accelerated the heart (which he designated Acceleransstoff, later identified as adrenaline/noradrenaline).

Dale, upon learning of Loewi’s findings, immediately recognized that the pharmacological properties of Vagusstoff matched those of acetylcholine. Dale and Loewi forged an intellectual alliance, proposing that synaptic transmission throughout the animal kingdom was fundamentally neurohumoral. Dale addressed the structural necessity of chemical transmission: the cell theory and the neuron doctrine demanded an anatomical discontinuity between the axon terminal and the effector cell. Biological cell membranes are composed of high-resistance lipid-protein matrices bathed in a low-resistance interstitial saline medium. A macroscopic electrical current propagating down a microscopic axon would, upon hitting the expanded fluid volume of the synaptic cleft, short-circuit instantaneously into the low-resistance extracellular fluid, leaving virtually no residual current density to depolarize the vast post-junctional muscle membrane.

Dale argued that a chemical transmitter acted as a biological amplifier: the electrical wave of the nerve impulse arrives at the terminal and triggers the secretion of a chemical packet, which diffuses across the infinitesimal nanometer-scale cleft to unlock localized ionic conductance channels. In response to the critique of diffusion kinetics, Dale and Loewi insisted that the spatial dimensions of the synaptic cleft were microscopic, reducing diffusion transit times to negligible values, provided that an active enzyme was present on site to ensure the absolute termination of the chemical signal.

3.3 Epistemological and Methodological Divergence

The intractable nature of the Soups vs. Sparks dispute stemmed from a profound epistemological divide between two scientific cultures. Electrophysiologists operated within the paradigm of high-speed instrumentation: they utilized string galvanometers, capillary electrometers, and cathode-ray oscillographs to capture dynamic physiological phenomena occurring across milliseconds. Their training predisposed them to view the organism as an integrated electrical network, and they regarded pharmacologists as chemical interventionists who violently disrupted living systems by dousing complex organs in toxic alkaloids, observing secondary, non-physiological responses.

Pharmacologists, conversely, were grounded in synthetic chemistry, analytical isolation, and organ bath bioassays. They recognized that bioelectrical recordings, for all their temporal precision, were non-specific: an electrical trace registers voltage changes, but reveals nothing regarding the underlying molecular, conformational, or metabolic transactions that produce those voltage changes. Pharmacologists maintained that the electrophysiologists were confusing the consequence of an event with its cause—mistaking the electrical endplate potential for the primary transmission mechanism, rather than recognizing it as the downstream bioelectrical result of an upstream chemical-receptor interaction.

These theoretical battles played out before the gathered luminaries of the British Physiological Society during the early 1930s. At meetings in London, Oxford, and Cambridge, Eccles and his allies repeatedly attacked the chemical hypothesis, demanding that Dale demonstrate the liberation of acetylcholine from voluntary skeletal muscle during physiological twitches. The burden of proof imposed upon Dale was immense: he had to capture an evanescent molecule that was presumed to be destroyed in less than a millisecond, in quantities that stretched the absolute limits of physical detection, from an anatomically complex muscular organ crisscrossed by blood vessels, connective tissues, and sympathetic autonomic nerves.

4. The 1936 Breakthrough: Experimental Architecture of Dale, Feldberg, and Vogt

The definitive empirical vindication of the chemical doctrine at the neuromuscular junction was achieved not by philosophical debate, but by an experimental triumph conducted at the National Institute for Medical Research at Mount Vernon, Hampstead. There, Henry Dale assembled a team possessing an unparalleled combination of surgical skill, microdissection capability, and bioassay expertise.

4.1 Collaborative Synergy: Dale, Wilhelm Feldberg, and Marthe Vogt

The research triad assembled by Dale in 1934 was an extraordinary alignment of scientific talent. In the wake of the National Socialist regime’s rise in Germany, Wilhelm Feldberg, an exceptional young pharmacologist working at the Physiological Institute of the University of Berlin, was expelled from his academic post due to his Jewish heritage. Dale, recognizing Feldberg’s genius and humanitarian plight, secured Rockefeller Foundation funding to bring him to Hampstead. Feldberg brought an invaluable experimental methodology: he had perfected the use of the sensitized dorsal muscle of the medicinal leech (Hirudo medicinalis) as an ultra-sensitive, reliable biological assay for acetylcholine, capable of detecting picomolar concentrations that defied all contemporary physical or chemical instrumentation.

Joining Dale and Feldberg was Marthe Louise Vogt, the brilliant daughter of the celebrated German neuroanatomists Cécile and Oskar Vogt. Vogt possessed world-class surgical precision, a mastery of complex vascular perfusion techniques, and an uncompromising dedication to quantitative controls. Dale provided the theoretical direction, philosophical rigor, and experimental framework. Together, this triumvirate designed a multi-stage experimental architecture that subjected the skeletal neuromuscular junction to an analytical assault unprecedented in its thoroughness.

4.2 Selection of the Mammalian Skeletal Muscle Preparations

To eliminate ambiguity, the Hampstead team recognized that they had to work with mammalian somatic muscles whose vascular architecture could be completely isolated, and whose motor innervation was entirely devoid of sympathetic autonomic contamination. After exhaustive anatomical reconnaissance, Dale, Feldberg, and Vogt selected two primary preparations in the domestic cat (Felis catus): the cat tongue preparation and the feline gastrocnemius/quadriceps femoris preparation.

The cat tongue preparation was surgically immaculate. The tongue is innervated with motor control exclusively by the hypoglossal nerve (Cranial Nerve XII). This large motor trunk can be dissected free in the neck, mobilized, and placed on non-polarizable stimulating electrodes without impinging upon autonomic pathways. The sensory lingual nerve and the sympathetic cervical trunks could be surgically transected and extirpated. Furthermore, the vascular supply to the tongue, mediated via the lingual arteries and drained via the external jugular venous branches, could be cannulated to establish an isolated perfusion circuit. This allowed the investigators to wash the tissue free of systemic blood and collect venous fluid that had traversed only the skeletal muscle beds of the tongue during hypoglossal stimulation.

The second model was the hindlimb gastrocnemius and quadriceps femoris preparation, innervated via the sciatic and femoral nerves. To ensure that the fluid collected from this vascular circuit was not contaminated by autonomic postganglionic sympathetic fibers (which travel extensively within somatic nerve trunks to supply blood vessels), Dale, Feldberg, and Vogt performed preliminary aseptic surgeries on the experimental animals weeks prior to the acute experiment. They excised the lumbar sympathetic chain from the abdominal cavity. This chronic pre-ganglionic sympathectomy caused all postganglionic sympathetic adrenergic fibers in the hindlimb to undergo complete Wallerian degeneration, leaving the motor nerve trunks populated purely by voluntary, somatic motor axons.

4.3 The 1936 Landmark Paper: Structure and Objectives

The experimental campaign culminated in the publication of their definitive masterpiece in the Journal of Physiology in 1936, titled: “Release of acetylcholine at voluntary motor nerve endings” (Dale, Feldberg, and Vogt, 1936). The objective of this paper was not simply to suggest the plausibility of chemical transmission, but to establish a multi-tiered, definitive proof that met Dale’s criteria.

The experimental protocol was designed with systematic sequencing. For each animal preparation, the muscular bed was perfused under strictly controlled hydrodynamic pressure. Venous effluent was continuously collected and partitioned into distinct temporal fractions:
Fraction 1: The basal collection during complete physiological rest, establishing the non-existence or baseline leakage of active principles.
Fraction 2: The collection obtained during rhythmic electrical stimulation of the isolated motor nerve trunk at physiological frequencies, evoking rhythmic motor unit contractions.
Fraction 3: The post-stimulation recovery collection, verifying that the chemical substance ceased to appear once electrical excitation was terminated.

The paper systematically addressed and dismantled every alternative explanation that the sparks camp had constructed or could construct, including vascular trauma, generalized tissue damage, cellular leakage due to mechanical distortion, and autonomic artifacts. The resulting document became a masterclass in the logic of experimental physiology.

5. Methodological Ingenuity: Perfusion Techniques and Anticholinesterases

The realization of Dale, Feldberg, and Vogt’s experimental goals depended upon solving a seemingly insurmountable biochemical problem: acetylcholine’s lifespan in native extracellular fluids is measured in thousandths of a second. Dale’s own predictions had asserted that without rapid enzymatic degradation, neuromuscular transmission could not function. Paradoxically, this meant that the very molecule they sought to detect was systematically destroyed at its site of release before it could traverse the microvascular endothelium and enter the venous collection cannula.

5.1 Overcoming the Rapid Enzymatic Hydrolysis of Acetylcholine

The Hampstead triad recognized that to collect acetylcholine in venous effluent, they had to establish a temporary biochemical shield that paralyzed the endogenous tissue esterases without poisoning the physiological machinery responsible for nerve conduction, neurotransmitter synthesis, and presynaptic release. The chemical key that unlocked this door was the indole alkaloid physostigmine, historically known as eserine, extracted from the Calabar bean (Physostigma venenosum).

Earlier biochemical investigations, notably those of Edgar Stedman and Ellen Stedman in Edinburgh, had identified the enzyme responsible for acetylcholine hydrolysis as “cholinesterase” and demonstrated that eserine acted as a competitive inhibitor of this catalytic process. Dale, Feldberg, and Vogt realized that if eserine was administered to their perfusion solutions in micro-concentrations, it would bind to and reversibly inhibit the active catalytic sites of both tissue-bound and circulating cholinesterases. Acetylcholine liberated from presynaptic terminals would survive its transit across the interstitial fluid, enter the venous capillaries intact, and emerge in the collected effluent.

The experimental titration of eserine was exceptionally delicate. If the concentration was too low, the esterases remained active, and the venous effluent was completely devoid of biological activity. If the concentration was too high, the drug risked inducing direct pharmacological blockade of axonal conduction or producing neuromuscular desensitization. Through methodical trial and error, they determined that an eserine concentration of roughly 1:1,000,000 to 1:500,000 within the perfusion fluid served as an optimal protective screen. In control experiments conducted in the complete absence of eserine, vigorous electrical stimulation of the motor nerves elicited zero detectable acetylcholine in the venous fluid, verifying that endogenous cholinesterase was naturally sufficient to destroy every trace of the liberated transmitter.

5.2 Microperfusion Methodology of Skeletal Muscle Beds

To avoid the enzymatic and physical complexities of native whole blood—such as red blood cell acetylcholinesterase, plasma pseudocholinesterase, and plasma protein binding—Dale, Feldberg, and Vogt replaced the animal’s circulation within the experimental limb with artificial vascular perfusion. They utilized an oxygenated, warmed Ringer-Locke saline solution (containing precise millimolar ratios of sodium chloride, potassium chloride, calcium chloride, sodium bicarbonate, and glucose), modified to maintain physiological osmolarity and buffered to a pH of 7.4.

The surgical cannulation demanded extraordinary technical dexterity. Operating under deep chloralose or ether anesthesia, the target artery (such as the lingual or femoral) was isolated, ligated proximally, and cannulated with a specialized glass cannula connected to an elevated perfusion reservoir. A constant hydrostatic pressure head was maintained to ensure an unvarying, physiological perfusion rate through the muscular capillary bed. The venous drainage was similarly mobilized and cannulated, allowing the total venous return from the muscle to flow freely into chilled, graduated collection tubes.

The investigators took extreme precautions to preserve the physiological viability of the isolated tissue throughout hours of continuous perfusion. The perfusion fluid was continuously bubbled with a gas mixture of 95% oxygen and 5% carbon dioxide (carbogen) to prevent hypoxia and acidosis. The entire preparation was housed within a heated moist chamber to maintain strict normothermia. The muscle was secured to rigid metal stands with fine surgical clamps to eliminate mechanical strain artifacts on the cannulated microvessels during motor contractions, thereby preventing vascular stasis, shearing, or ischemia.

5.3 The Dorsal Leech Muscle and Frog Rectus Abdominis Bioassays

In 1936, no spectrophotometer, mass spectrometer, or radioimmunoassay possessed the sensitivity to measure the nanomolar and picomolar quantities of acetylcholine expected to survive tissue transit. Dale and his team had to rely upon living biological indicators—quantitative tissue bioassays calibrated to respond selectively to trace amounts of the choline ester.

The primary bioassay instrument was the sensitized dorsal muscle of the leech, a technique pioneered by Minz and refined by Feldberg. A longitudinal strip of the body-wall muscle of Hirudo medicinalis was dissected, suspended in a tiny, temperature-controlled organ bath containing oxygenated Ringer’s solution, and connected to a light, balanced lever that transcribed its mechanical movements onto a soot-blackened kymograph drum. When the leech muscle preparation was pre-treated with eserine (which sensitized it to acetylcholine by several orders of magnitude), it responded to acetylcholine with a slow, smooth, dose-dependent contracture. The leech assay was remarkably selective: it remained completely indifferent to inorganic ions, amino acids, adrenaline, and breakdown products of muscle metabolism, yet it reacted with repeatable contractions to acetylcholine concentrations as low as one part in one billion (1:1,000,000,000).

To provide definitive pharmacological cross-validation, Dale and his colleagues parallel-tested their venous samples on a second, distinct biological preparation: the isolated rectus abdominis muscle of the frog (Rana temporaria). This muscle, highly sensitive to nicotinic agonists, generated a rapid contracture when exposed to acetylcholine in the presence of eserine. By comparing the unknown venous effluent simultaneously across both the leech and frog rectus preparations against standardized, freshly prepared solutions of pure synthetic acetylcholine, the researchers generated matching quantitative calibration curves.

Finally, the Hampstead team implemented an ironclad chemical control: alkaline hydrolysis. Acetylcholine is an ester, and its ester bond is unstable under alkaline conditions; boiling an acetylcholine solution at an alkaline pH (pH > 10) for several minutes completely hydrolyzes the molecule into choline and acetate, abolishing its biological activity. In contrast, other endogenous biologically active amines, such as histamine or adrenaline, retain their activity under such conditions. In every single trial, when Dale and his colleagues boiled their collected venous effluent with mild sodium hydroxide, the biological stimulant activity on both the leech and the frog rectus preparations vanished completely, proving that the active principle was indeed an unstable choline ester.

6. Empirical Proof of Evoked Acetylcholine Release

With their experimental architecture in place, Dale, Feldberg, and Vogt executed the definitive series of experiments designed to capture and characterize the chemical messenger released during voluntary motor stimulation.

6.1 Direct Stimulation of Somatic Motor Fibers

The initial protocol established the baseline conditions. With the perfusion fluid running continuously through the eserinized tongue or gastrocnemius bed, the effluent collected during the resting, uninhibited state was applied directly to the leech muscle organ bath. The kymograph recording showed a flat, uninterrupted baseline: in the resting state, no detectable acetylcholine escaped into the venous outflow. The quiescent neuromuscular junction was chemically silent.

The isolated motor nerve—the hypoglossal or the sympathectomized sciatic—was then placed across platinum stimulating electrodes connected to an electrical induction coil. A train of rhythmic, physiological electrical impulses was delivered to the nerve trunk. Immediately, the skeletal muscle responded with vigorous, coordinated twitches. Simultaneously, the venous effluent collected during this period of stimulation was tested on the sensitized bioassays. The response was immediate: the leech muscle contracted into a prolonged, maximal contracture, and the frog rectus abdominis shortened in parallel.

The investigators systematically varied the parameters of electrical stimulation. They demonstrated a direct, proportional relationship between the frequency and duration of motor nerve stimulation and the concentration of acetylcholine recovered in the venous effluent. When the stimulation frequency was increased within physiological limits (from 5 to 50 impulses per second), the yield of acetylcholine rose correspondingly. The moment the electrical stimulation of the motor nerve was switched off, the skeletal muscle twitches ceased, and subsequent collections of venous effluent revealed a rapid decay in acetylcholine concentration, returning to absolute baseline within minutes. The release of the chemical was temporally and quantitatively coupled to the passage of motor nerve impulses.

6.2 Excluding Muscle Contraction as the Source of Acetylcholine

The critical intellectual objection raised by John Eccles and the electrical school was instantaneous: how could Dale prove that the detected acetylcholine originated from the microscopic presynaptic nerve terminals, rather than being released as a non-specific metabolic byproduct of the mechanical distortion and chemical upheaval occurring within the contracting muscle fibers themselves? A contracting muscle fiber undergoes dramatic biochemical shifts, involving glycogenolysis, ATP breakdown, potassium efflux, and membrane deformation. The electrophysiologists argued that acetylcholine might be a trivial metabolic waste product squeezed out of the working sarcoplasm.

To dismantle this objection, Dale, Feldberg, and Vogt designed two ingenious counter-experiments that dissociated the mechanical contraction of the muscle from the electrical stimulation of the nerve.

In the first experiment, they subjected the skeletal muscle to direct electrical stimulation in the absence of nerve excitation. Using muscles in which the motor nerves had been transected and allowed to degenerate, they applied electrical currents directly across the muscle belly. The muscle fibers responded with powerful, sustained contractions that equaled or exceeded the mechanical force generated by indirect nerve stimulation. Yet, upon collecting and bioassaying the venous effluent from these violently working, directly excited muscles, not a trace of acetylcholine was detected. Mechanical contraction per se, regardless of its intensity, was incapable of generating or releasing acetylcholine.

In the second, reciprocal experiment, Dale and his team utilized pharmacological uncoupling via curare. They infused a concentration of curare sufficient to induce complete neuromuscular paralysis. When electrical shocks were delivered to the motor nerve trunk, the nerve conducted normally (as verified by electrical recordings), but the muscle remained flaccid, displaying zero mechanical twitch or electrical action potential. Yet, when the venous effluent collected during this nerve stimulation under complete curarization was applied to the leech muscle, acetylcholine was recovered in identical quantities to that observed in unparalyzed preparations. The release of the chemical was independent of the mechanical contraction of the post-junctional muscle, localizing the origin of the acetylcholine to the presynaptic motor nerve terminals.

6.3 Investigations Following Chronic Nerve Degeneration

To provide anatomical proof that acetylcholine release was localized exclusively to the axonal terminals, Dale, Feldberg, and Vogt performed chronic nerve sectioning experiments. Under sterile surgical conditions, they severed the motor nerves (such as the hypoglossal nerve) supplying one half of the tongue or the sciatic nerve of one limb, leaving the contralateral side intact as an internal control.

The animals were allowed to recover for days to weeks. During this survival period, the severed peripheral axons underwent complete Wallerian degeneration: the axonal cytoplasm disintegrated, the terminal arborizations collapsed, and the presynaptic structures were phagocytosed by Schwann cells, leaving the muscle fiber membranes and their post-junctional endplates structurally intact but completely denervated. Once degeneration was histologically complete, the acute perfusion experiment was repeated.

When the degenerated nerve stump was subjected to electrical stimulation, no nerve conduction could occur, and zero acetylcholine was detected in the venous effluent. More importantly, when the chronically denervated muscle was excited directly with electrical currents, causing violent mechanical shortening of the sarcoplasm, the eserinized venous effluent remained devoid of any choline ester. Furthermore, quantitative biochemical extractions performed on the chronically denervated muscle tissue demonstrated a dramatic, near-total disappearance of acetylcholine and its synthesizing capacity from the organ. These experiments confirmed that the presence, storage, and physiological release of acetylcholine were dependent upon the presence of structurally intact motor nerve axons and terminals.

7. Pharmacological Replication: Close Intra-Arterial Injections

Having proven that acetylcholine is naturally liberated from motor terminals during excitation, Dale was left with the second half of the physiological burden of proof: he had to show that acetylcholine, when artificially applied to the motor endplate, could faithfully reproduce the precise, millisecond kinetics of a physiological nerve impulse. Skeletal muscle twitches are not slow, sustained contractures; they are lightning-fast, synchronous contractions. Demonstrating that exogenous acetylcholine could mimic this behavior represented an extraordinary experimental challenge.

7.1 The Challenge of Intravenous vs. Intra-Arterial Administration

Opponents of the chemical theory had consistently pointed out that when acetylcholine was injected into the systemic circulation (such as via the femoral or jugular vein), it failed to produce anything resembling a skeletal muscle twitch. Instead, the animal experienced cardiovascular collapse, bradycardia, bronchoconstriction, and at best, an irregular, slow muscle fibrillation or twitching that was clearly unphysiological. Eccles argued that if acetylcholine were the true transmitter of voluntary movement, its systemic introduction should trigger an instantaneous, coordinated twitch of all skeletal musculature.

Dale and his colleague, the biophysicist George Lindor Brown, exposed the biological fallacy of this objection. When a drug is introduced intravenously, it undergoes massive dilution within the central blood volume, is partially hydrolyzed by plasma esterases, and arrives at the skeletal muscle beds in a slow, dispersed, low-concentration wave. Because the muscle fibers within an intact motor unit must be depolarized almost simultaneously within a fraction of a millisecond to achieve mechanical summation and a synchronous twitch, a slow, diluted wave of acetylcholine merely produces desensitization or asynchronous, localized miniature contractions.

To overcome this pharmacokinetic barrier, Dale, Feldberg, and Brown (1936) developed the revolutionary technique of close intra-arterial injection. They exposed the arterial supply immediately adjacent to the muscle bed (such as the lingual artery supplying the tongue or the popliteal artery supplying the gastrocnemius). They tied off all collateral vascular branches, inserted a finely drawn glass micro-cannula directly into the lumen of the main feeding artery, and positioned the tip millimeters from the capillary network of the muscle. This enabled them to deliver a micro-bolus of acetylcholine directly into the muscular microcirculation within a transit time of less than a few hundredths of a second, bypassing systemic dilution entirely.

7.2 Mimicking the Mechanical Twitch of Physiological Impulses

The results of close intra-arterial injection were breathtaking. When Dale, Feldberg, and Brown injected a minute bolus of acetylcholine—containing merely a fraction of a microgram (often between 0.1 and 2.0 micrograms) dissolved in a few tenths of a milliliter of saline—directly into the arterial supply of the cat gastrocnemius muscle, the muscle responded not with a sluggish contracture, but with a violent, synchronous, instantaneous mechanical twitch.

The mechanical tracing of this contraction, recorded on a high-speed isometric myograph, was indistinguishable from the mechanical twitch elicited by a maximal electrical shock delivered directly to the motor nerve. The contraction exhibited an explosive rate of tension development, followed by an immediate, clean relaxation. When they simultaneously attached electromyographic recording electrodes to the muscle, they observed that the close arterial injection of acetylcholine evoked a synchronous, high-voltage wave of depolarization—a motor action potential—that swept across the muscle fibers with the same velocity and electrical morphology as an impulse initiated by neural excitation.

By adjusting the dosage of acetylcholine injected intra-arterially, Dale and Brown demonstrated that they could graduate the mechanical response with quantitative fidelity. Tiny doses produced fractional twitches corresponding to the recruitment of individual motor units, while optimal doses produced a maximal, synchronous tension output equal to the tetanic tension of the muscle. This experiment dismantled the argument that acetylcholine could only provoke slow autonomic adjustments, demonstrating that its kinetics at the motor endplate were fully capable of driving voluntary motor movements.

7.3 The Action of Curare and Nicotine at the Endplate

The final requirement of the pharmacological replication was to verify that exogenous acetylcholine and endogenous motor nerve impulses acted through the identical macromolecular receptive mechanism. This was demonstrated through the classical pharmacology of competitive and non-competitive antagonism at the motor endplate.

In the mid-nineteenth century, Claude Bernard had conducted his legendary experiments with curare, the South American indigenous arrow poison. Bernard demonstrated that curare abolished neuromuscular transmission while leaving the conduction of the motor nerve trunk and the direct electrical excitability of the muscle fiber completely intact. Dale, Feldberg, and Brown applied this tool to their close intra-arterial system. When they administered a small, paralyzing dose of curarine to the arterial supply, the mechanical twitch elicited by electrical stimulation of the motor nerve was abolished. Crucially, when they subsequently injected an otherwise maximal twitch-producing dose of acetylcholine into the same artery, the response was completely blocked.

As the curare gradually washed out of the vascular bed, the sensitivity of the endplate returned in parallel: the response to motor nerve stimulation and the response to close intra-arterial acetylcholine recovered concurrently, following an identical temporal curve of restoration. This showed that both the endogenous transmitter liberated by the nerve and the exogenous acetylcholine injected via the cannula competed for the identical “receptive substance” described by Langley.

Furthermore, Dale investigated the effects of elevated concentrations of nicotine and high doses of acetylcholine itself. They demonstrated that while low doses stimulated the endplate, excessive concentrations induced a persistent depolarization of the junctional region that rapidly degenerated into complete neuromuscular paralysis—a phenomenon now recognized as depolarizing blockade and receptor desensitization. The pharmacology of the endplate was shown to be coherent, self-consistent, and grounded in the specific, ligand-gated properties of an acetylcholine receptor.

8. Dale’s Principle and the Theoretical Codification of Neurochemistry

The success of the 1936 neuromuscular experiments catalyzed a complete re-conceptualization of the functional architecture of the entire nervous system. Dale used this empirical platform to construct a systematic theoretical foundation for neurochemistry, establishing conceptual classifications that unified disparate branches of biology.

8.1 The Formulation of Dale’s Principle

In his 1935 Walter Ernest Dixon Memorial Lecture, delivered before the Royal Society of Medicine, Dale reflected upon the broader implications of chemical transmission. He considered the biological nature of the neuron: a single, highly arborized eukaryotic cell possessing a cell body, multiple dendrites, and an axon that divides into hundreds or thousands of terminal branches, occasionally synapsing on widely divergent targets (such as central recurrent collateral branches and peripheral somatic muscles).

Dale hypothesized that a neuron, being a unified metabolic and biochemical entity, must utilize the same chemical transmitter machinery throughout all its protoplasmic terminals. This conceptual postulate was later codified and designated by John Eccles in the 1950s as “Dale’s Principle”. In its classical formulation, Dale’s Principle states that a given neuron synthesizes, stores, and releases the identical chemical neurotransmitter substance at all of its synaptic terminations, central or peripheral.

The immediate application of Dale’s Principle was brilliantly verified in the 1950s by John Eccles, Victor Fatt, and Kosuke Koketsu during their studies of the motor axon collaterals within the mammalian spinal cord. Somatic alpha motor neurons possess axon collaterals that terminate internally upon inhibitory interneurons (the Renshaw cells) within the ventral horn. Applying Dale’s principle, they predicted that if the alpha motor neuron utilizes acetylcholine at its peripheral neuromuscular junction, it must also liberate acetylcholine from its central recurrent collaterals within the spinal cord. Intracellular recordings and pharmacological probing confirmed this prediction: the excitation of Renshaw cells by motor axon collaterals was blocked by curare and potentiated by anticholinesterases, providing proof that central transmission was governed by identical chemical laws.

While modern molecular neuroscience has revised Dale’s Principle to accommodate phenomena such as co-transmission (wherein a classic neurotransmitter is co-released alongside one or more neuropeptides, such as acetylcholine with VIP, or ATP with noradrenaline) and neurotransmitter switching during developmental plastic phases, the core axiom remains a foundation of modern neurobiology: a neuron exhibits a coherent, regulated neurochemical identity across its arborizations.

8.2 The Adrenergic vs. Cholinergic Classification System

Prior to Dale’s work, the classification of the autonomic and somatic nervous systems was based on gross anatomical geography: the division between the craniosacral parasympathetic outflow and the thoracolumbar sympathetic outflow. This anatomical taxonomy was plagued by physiological contradictions and functional anomalies. For instance, the postganglionic sympathetic fibers innervating the sweat glands of the skin in humans and cats anatomically emerge from the sympathetic chain, yet their physiological actions are activated by pilocarpine and inhibited by atropine—a pharmacological profile characteristic of the parasympathetic system.

To resolve this chaos, Dale, in a landmark 1933 paper titled “Nomenclature of fibres in the autonomic system and their chemical transmission,” proposed an entirely new classification scheme based on the nature of the chemical transmitter liberated at the nerve terminal, rather than its embryological or anatomical lineage. He coined the terms that remain foundational to modern medicine:

• Cholinergic: Designating all nerve fibers that operate via the synthesis, storage, and release of acetylcholine as their primary chemical messenger.
• Adrenergic: Designating all nerve fibers that operate via the release of adrenaline-like substances (later conclusively identified by Ulf von Euler as noradrenaline) as their primary chemical messenger.

Dale’s chemical classification resolved the long-standing anomalies. The sympathetic innervation of sweat glands was classified simply as sympathetic cholinergic fibers, resolving the anatomical paradox. Crucially, Dale placed the voluntary somatic motor nerves firmly within the cholinergic family. Thus, the motor nerves supplying the quadriceps femoris, the preganglionic fibers of the sympathetic ganglia, and the postganglionic parasympathetic fibers innervating the heart were all recognized as members of a single, unified neurochemical lineage.

8.3 The Concept of the Neurochemical Cascade

The work of Dale and his collaborators laid the conceptual groundwork for what modern biochemistry defines as the neurochemical cascade of the synapse. By viewing the nerve terminal as a specialized secretory organ, Dale established the theoretical template for the complete lifecycle of a neurotransmitter:

• Synthesis: The localized intracellular generation of the transmitter from metabolic precursors (later isolated as the enzymatic acetylation of choline by choline acetyltransferase).
• Storage: The sequestration of the synthesized transmitter within presynaptic compartments shielded from metabolic degradation.
• Stimulus-Secretion Coupling: The mobilization and evacuation of the transmitter pool in response to the arrival of an electrical depolarization.
• Post-Junctional Receptor Activation: The binding of the transmitter to specific macromolecular receptive complexes on the effector membrane, initiating changes in ionic permeability.
• Rapid Inactivation: The immediate, localized enzymatic destruction or re-uptake of the transmitter to reset the physiological switch.

Furthermore, Dale’s operational separation of muscarinic and nicotinic actions anticipated the modern distinction between metabotropic (slow, G-protein-coupled) receptors and ionotropic (fast, ligand-gated ion channel) receptors. The nicotinic acetylcholine receptor at the neuromuscular junction emerged as the prototype of all fast ionotropic receptors, capable of mediating millisecond-scale electrical changes across cell membranes.

9. Resolution of the Synaptic Controversy and the 1936 Nobel Prize

The empirical clarity of the 1936 Hampstead papers altered the trajectory of the synaptic debate, drawing international recognition and forcing the champions of the electrical doctrine to reconsider their biophysical assumptions.

9.1 The Awarding of the 1936 Nobel Prize in Physiology or Medicine

In October of 1936, within months of the publication of the definitive skeletal muscle papers, the Nobel Committee for Physiology or Medicine announced that the 1936 Nobel Prize was awarded jointly to Sir Henry Hallett Dale and Otto Loewi “for their discoveries relating to chemical transmission of nerve impulses”.

The Nobel citation acknowledged the symbiotic relationship between Loewi’s fundamental discoveries in the amphibian autonomic nervous system and Dale’s systematic identification, classification, and empirical proof of chemical transmission across both autonomic ganglia and voluntary skeletal muscle. In its presentation speech, the Nobel Committee emphasized that Dale’s triumph in demonstrating chemical transmission at the somatic motor endplate was the decisive achievement that transformed the chemical hypothesis from an interesting autonomic specialization into a universal biological law governing the animal kingdom.

The historical backdrop of the 1936 Nobel Prize was marked by dark political currents. In March 1938, following the Nazi annexation of Austria (the Anschluss), Otto Loewi was arrested in Graz by the Gestapo due to his Jewish heritage, imprisoned, and stripped of his Nobel prize money. Dale intervened with intense international diplomatic efforts, utilizing his influence as Director of the National Institute for Medical Research to help secure Loewi’s release and safe passage to England and eventually to the United States. The solidarity between Dale and Loewi symbolized the defense of scientific rationalism and human dignity during an era of totalitarian crisis.

9.2 John Eccles’ Concession and Conversion to Chemical Transmission

Despite the awarding of the Nobel Prize, John Eccles remained resistant. Throughout the late 1930s and the 1940s, Eccles continued to formulate increasingly elaborate mathematical variations of his electrical hypothesis, focusing heavily on the newly discovered endplate potential (EPP). Eccles, along with Stephen Kuffler, demonstrated that when a motor nerve is stimulated, the muscle endplate generates a localized, non-propagated depolarization wave that precedes the fully propagated action potential. Eccles argued that this EPP was generated by the electrical action currents of the nerve terminal, whereas acetylcholine was merely an unimportant secondary substance whose role was, at best, to produce a slow, background depolarization.

The technical revolution of the late 1940s brought the definitive resolution. In 1949, Gilbert Ling and Ralph Gerard invented the intracellular glass microelectrode—a pulled-glass capillary with a tip diameter of less than 0.5 micrometers, filled with a concentrated electrolyte solution (such as 3M potassium chloride), capable of penetrating the cell membrane without causing mechanical injury.

Eccles, operating at the University of Otago in New Zealand and later at the Australian National University in Canberra, embraced the intracellular microelectrode. Between 1950 and 1952, working alongside Paul Fatt and Bernard Katz, Eccles inserted microelectrodes directly into the cell bodies of spinal motoneurons. He recorded the intracellular potential changes during the activation of excitatory and inhibitory synaptic pathways. When Eccles recorded the inhibitory postsynaptic potential (IPSP), he observed a profound, unmistakable transient hyperpolarization of the neuronal membrane, driving the membrane potential more negative than its resting baseline.

This single observation delivered the death blow to the electrical hypothesis. An electrical eddy current entering a cell must produce inward current flows that cause depolarization; it is physically impossible for an electrical current coming from an action potential in a presynaptic terminal to generate a selective, hyperpolarizing reversal of membrane potential in a post-junctional cell without an intervening chemical-mediated shift in ionic permeability. In a legendary display of intellectual integrity, Eccles publicly conceded his error. In an address before the Physiological Society in 1952, Eccles renounced the electrical doctrine of the Sparks, declared his conversion to Dale’s chemical theory, and spent the remainder of his career elucidating the neurochemical mechanisms of synaptic transmission, an effort for which he was awarded the Nobel Prize in 1963.

9.3 Synthesis of Electrical and Chemical Paradigms

The ultimate resolution of the Soups vs. Sparks controversy was not the absolute annihilation of one paradigm by the other, but a magnificent physiological synthesis. The modern understanding of synaptic physiology recognizes that electrical and chemical mechanisms operate in an alternating, coordinated biophysical cascade:

The transmission cycle is fundamentally an electrical-chemical-electrical transduction:
1. Conduction along the axon is purely electrical (the self-propagating action potential driven by voltage-gated sodium and potassium channels).
2. Transmission across the synaptic discontinuity is purely chemical (voltage-gated calcium entry driving the exocytosis of acetylcholine, which diffuses across the cleft to bind nicotinic receptors).
3. Excitation of the effector sarcoplasm is once again purely electrical (the opening of ligand-gated non-selective cation channels generating the localized electrical endplate potential, which in turn fires the self-propagating muscle action potential).

Decades later, in the late 1950s and 1960s, electrophysiologists such as Edwin Furshpan, David Potter, and Michael Bennett discovered the existence of true electrical synapses—specialized intercellular structures composed of hexameric hemichannels known as connexins, which dock across a narrow 2-nanometer cleft to form continuous, low-resistance pore pathways known as gap junctions. These electrical synapses mediate instantaneous, bidirectional electrotonic coupling, precisely as Eccles had imagined decades earlier. However, nature has reserved these electrical synapses primarily for specialized niches requiring ultra-rapid synchronization (such as cardiac intercalated discs, smooth muscle syncytia, and specialized central neuronal clusters mediating escape reflexes), while assigning the vast majority of mammalian synaptic transactions to the chemical mechanisms championed by Henry Dale.

10. Biophysical and Ultrastructural Validation in the Post-Dale Era

In the decades that followed Dale’s 1936 publications, the chemical transmission model served as the conceptual launchpad for a series of biophysical, ultrastructural, and structural breakthroughs that validated Dale’s macroscopic predictions at the atomic and sub-cellular scale.

10.1 Bernard Katz and the Quantal Hypothesis of Neurotransmitter Release

In the early 1950s, at University College London, Bernard Katz (who was awarded the Nobel Prize in 1970), working in collaboration with Paul Fatt, introduced the intracellular microelectrode to the isolated amphibian and mammalian neuromuscular junction. In resting muscle fibers bathed in physiological Ringer’s solution containing eserine, Katz and Fatt observed an astonishing phenomenon: the oscillograph recorded continuous, spontaneous, microscopic electrical fluctuations at the motor endplate. These minute voltage deflections, which they named miniature endplate potentials (MEPPs), exhibited an identical kinetic shape to the full endplate potential, but possessed a stereotyped, uniform amplitude of approximately 0.5 to 1.0 millivolts.

Katz and Fatt demonstrated that these MEPPs were abolished by curare and lengthened by anticholinesterases, confirming that they were caused by the spontaneous impact of localized bursts of acetylcholine upon the endplate. Crucially, statistical analysis revealed that the amplitude of a normal, evoked endplate potential was not a continuous analog variable, but was composed of the synchronous mathematical summation of an integral number of these unitary, all-or-none miniature potentials.

From these rigorous data, Katz formulated the quantal hypothesis of neurotransmitter release. He proposed that acetylcholine is stored in and released from the presynaptic motor nerve terminal in discrete, pre-packaged multimolecular packets termed “quanta.” In the resting state, individual quanta are spontaneously discharged at a low stochastic frequency (roughly one quantum per second per junction), generating the baseline MEPPs. When the nerve action potential invades the terminal, the influx of extracellular calcium ions triggers a massive, synchronized increase in the probability of quantal discharge, causing the simultaneous release of hundreds of quanta (estimated at 100 to 300 quanta per action potential in mammalian junctions). Each quantum was calculated to contain approximately 5,000 to 10,000 molecules of acetylcholine. Katz’s quantal model provided the physical and mathematical confirmation of Dale’s assertion that chemical transmission could achieve the synchronization and explosive speed of an electrical impulse.

10.2 Electron Microscopy and the Identification of Synaptic Vesicles

While Katz was mathematically deducing the existence of multimolecular packets of acetylcholine, cell biologists were developing the tools required to visualize the microscopic architecture of the synapse. In the mid-1950s, George Palade, Sanford Palay, and J. David Robertson applied high-resolution transmission electron microscopy to thin-sectioned neuromuscular junctions, confirming Dale’s structural premises.

The electron micrographs revealed that the somatic motor endplate is characterized by an absolute physical discontinuity: the presynaptic axonal membrane is separated from the postsynaptic muscle sarcolemma by a clear, fluid-filled space measuring approximately 20 to 50 nanometers in width—the synaptic cleft. The high-resistance plasma membranes of the two cells never make continuous syncytial contact.

Within the cytoplasm of the presynaptic motor nerve terminal, electron microscopy revealed an astonishing sight: millions of uniform, membrane-bound spherical organelles measuring roughly 40 to 50 nanometers in diameter, which were christened synaptic vesicles. These vesicles, concentrated in dense clusters directly opposite specialized release sites known as “active zones,” were identified as the morphological correlates of Katz’s quanta and the physical storehouses of the acetylcholine predicted by Henry Dale.

Furthermore, electron microscopy revealed the post-junctional architecture of the skeletal muscle membrane. Directly beneath the active zones, the muscle membrane folds into deep, tortuous invaginations termed junctional folds. These folds serve to expand the surface area of the endplate by several orders of magnitude. Morphological and autoradiographic studies demonstrated that the crests of these junctional folds are packed with an extraordinary density of nicotinic acetylcholine receptors (roughly 10,000 to 20,000 receptors per square micrometer), placed directly in the line of fire of the liberating synaptic vesicles. Within the primary and secondary clefts, anchored within the basement membrane matrix, resides the enzyme acetylcholinesterase, positioned to destroy the liberated transmitter as it diffuses off its receptors.

10.3 Isolation and Structural Resolution of the Nicotinic Acetylcholine Receptor

In the late 1960s and 1970s, the biochemical identification of Langley’s “receptive substance” advanced from pharmacological deduction to structural isolation. This was made possible by the discovery of an exceptional biological model: the electric organs (electrocytes) of the electric ray (Torpedo marmorata) and electric eel (Electrophorus electricus). The electric organs are phylogenetically derived from modified embryonic skeletal muscle tissue, providing an exceptionally rich source of pure cholinergic synapses.

Jean-Pierre Changeux and his colleagues utilized specific snake venom toxins, notably alpha-bungarotoxin from the venom of the Taiwanese banded krait (Bungarus multicinctus), to isolate the receptor. Alpha-bungarotoxin binds to the nicotinic acetylcholine receptor with near-covalent irreversibility. By attaching alpha-bungarotoxin to affinity chromatography matrices, Changeux successfully isolated and purified the nicotinic acetylcholine receptor protein.

Subsequent biochemical and molecular cloning investigations revealed that the muscular nicotinic receptor is a pentameric macromolecular complex with a molecular weight of approximately 290 kilodaltons. It is composed of five homologous transmembrane glycoprotein subunits arranged in a pseudo-symmetric ring around a central ion-conducting pore, possessing the stoichiometric formula alpha2-beta-gamma-delta (in embryonic muscle) or alpha2-beta-epsilon-delta (in adult mammalian muscle). The binding of two acetylcholine molecules to the extracellular interfaces formed by the alpha subunits and adjacent subunits induces a sub-microsecond allosteric conformational shift, tilting the hydrophobic pore-lining M2 transmembrane helices outward. This conformational change opens a water-filled pore with a diameter of approximately 0.65 nanometers, allowing the non-selective passage of monovalent and divalent cations—primarily a massive inward flux of sodium ions driven by its electro-chemical gradient, accompanied by a smaller outward flux of potassium ions.

In 1976, Erwin Neher and Bert Sakmann developed the patch-clamp electrophysiology technique, for which they received the Nobel Prize in 1991. Applying patch-clamp pipettes to the skeletal muscle endplate, Neher and Sakmann accomplished what had once been deemed scientifically impossible: recording the real-time electrical current flowing through a single acetylcholine receptor channel. They demonstrated that in the presence of acetylcholine, individual channels snap open stochastically, allowing an elementary current of approximately 2 to 4 picoamperes to pass for a mean open time of roughly 1 millisecond. In recent years, advanced cryo-electron microscopy and X-ray crystallography have resolved the atomic coordinates of this channel, confirming the structural logic of Dale’s receptor model.

11. Clinical and Pharmacological Descendants of Dale’s NMJ Model

The experimental validation of chemical transmission at the neuromuscular junction transformed clinical medicine. Dale’s fundamental discoveries provided the conceptual framework required to understand neuromuscular pathophysiology, engineer modern surgical anesthesia, and devise interventions against chemical toxins.

11.1 Pathophysiology of Myasthenia Gravis and Autoimmune Channelopathies

For more than half a century, the debilitating disease known as Myasthenia Gravis—characterized by profound, exercise-induced, progressive skeletal muscle weakness and life-threatening respiratory failure—remained an untreatable mystery. In 1934, Dr. Mary Broadfoot Walker, a medical officer at St. Alfege’s Hospital in Greenwich, London, made a clinical deduction that transformed neurology. Walker, who closely followed Henry Dale’s emerging papers on acetylcholine and anticholinesterases, noted the striking pharmacological parallel between the muscle weakness of myasthenia gravis and the partial curarization of skeletal muscle described in Dale’s experiments.

Reasoning that myasthenia gravis might represent a pathological deficiency of acetylcholine action at the motor endplate, Walker administered an injection of physostigmine (and later its synthetic derivative, neostigmine) to a patient incapacitated by myasthenic ptosis, dysphagia, and limb paralysis. Within thirty minutes, in what is remembered as the “Miracle of St. Alfege’s,” the patient’s muscular strength returned to near-normal. Walker’s clinical breakthrough was an immediate, direct translation of Dale’s basic science to the bedside, inaugurating the pharmacological therapy of the disease.

Four decades later, in 1973, Jim Patrick and Jon Lindstrom established the precise autoimmune molecular etiology of myasthenia gravis. They demonstrated that immunization of rabbits with purified Torpedo nicotinic acetylcholine receptors produced an animal model of myasthenic weakness. Subsequent investigations verified that human myasthenia gravis is an autoimmune channelopathy driven by pathogenic IgG autoantibodies directed primarily against the extracellular alpha subunits of the postsynaptic nicotinic acetylcholine receptor. These autoantibodies impair transmission via three distinct mechanisms: direct competitive blockade of the acetylcholine binding pocket; complement-mediated membrane destruction of the junctional folds; and cross-linking of receptors leading to accelerated endocytosis and degradation. Modern therapy directly descends from Dale’s model: long-acting acetylcholinesterase inhibitors (such as pyridostigmine) enhance the residence time of acetylcholine within the synaptic cleft, compensating for the reduced receptor density, while targeted immunomodulation and plasmapheresis neutralize the underlying autoimmune attack.

A second clinical channelopathy, Lambert-Eaton Myasthenic Syndrome (LEMS), provides the reciprocal presynaptic counterpart. In LEMS, autoantibodies target the voltage-gated P/Q-type calcium channels situated within the active zones of the presynaptic motor terminal. This reduces calcium influx during the arrival of the action potential, resulting in a dramatic failure of quantal exocytosis—a direct disruption of the stimulus-secretion coupling predicted by the Hampstead experiments.

11.2 Anesthesia and Neuromuscular Blockade in Surgery

Until the mid-twentieth century, major abdominal, thoracic, and orthopedic surgeries required extraordinarily deep levels of general inhalation anesthesia (using toxic volatile agents such as ether, chloroform, or cyclopropane) to produce the profound skeletal muscle relaxation necessary to prevent involuntary reflex movement, allow surgical incision, and permit mechanical ventilation. These deep anesthesias carried severe rates of cardiovascular collapse, respiratory depression, and post-operative mortality.

In 1942, the Canadian anesthesiologists Harold Griffith and Enid Johnson fundamentally altered the discipline of anesthesiology by introducing an extract of curare (Intocostrin, containing purified d-tubocurarine) into human surgical practice. Drawing upon the pharmacological mechanisms elucidated by Dale, Feldberg, and Brown, Griffith recognized that curare could be deployed as an adjuvant to achieve targeted muscular paralysis without deepening the central anesthetic plane. The introduction of curare transformed anesthesia from a blunt, single-agent depression of the central nervous system into the modern triad of balanced anesthesia: hypnosis, analgesia, and neuromuscular blockade.

The pharmaceutical industry subsequently synthesized refined analogues designed to eliminate the histamine-releasing and autonomic ganglion-blocking side effects of d-tubocurarine. These modern agents are divided mechanistically into two broad classes:

• Non-Depolarizing Neuromuscular Blockers: Competitive antagonists of the nicotinic receptor (such as vecuronium, rocuronium, and cisatracurium) that bind to the alpha subunits without gating the channel, competitively preventing acetylcholine from binding. When surgery concludes, this blockade is pharmacologically reversed by administering acetylcholinesterase inhibitors (such as neostigmine, co-formulated with the muscarinic antagonist glycopyrrolate to shield the heart from bradycardia), which causes an accumulation of endogenous acetylcholine that displaces the competitive blocker. More recently, targeted encapsulation drugs, such as sugammadex (a modified gamma-cyclodextrin), have been introduced to bind and sequester rocuronium directly within the plasma, terminating its neuromuscular action.
• Depolarizing Neuromuscular Blockers: Prototyped by succinylcholine (suxamethonium), which consists of two linked acetylcholine molecules. Succinylcholine binds to the nicotinic receptor and gates the channel, producing an initial phase of uncoordinated muscle fasciculations. Because succinylcholine is not hydrolyzed by acetylcholinesterase (being metabolized slowly by plasma pseudocholinesterase), it persists at the endplate, causing continuous, sustained depolarization. This sustained depolarization locks the voltage-gated sodium channels of the perijunctional muscle membrane into an inactive, refractory state, producing flaccid neuromuscular paralysis.

11.3 Toxicology: Organophosphates, Chemical Warfare, and Natural Neurotoxins

The central role of acetylcholinesterase in terminating transmission at the neuromuscular junction renders it a critical biological vulnerability, one that has been exploited by human weapon designers and nature alike.

During the 1930s and 1940s, German industrial chemists led by Gerhard Schrader synthesized the first generation of organophosphate anticholinesterases, initially intended as agricultural insecticides (such as parathion) and rapidly weaponized into catastrophic chemical warfare agents, including the G-series nerve agents (tabun, sarin, and soman) and the later V-series agents (such as VX). Organophosphates function as suicide inhibitors of acetylcholinesterase: their central phosphorus atom attacks the nucleophilic serine hydroxyl group situated within the catalytic triad of the enzyme’s active esteratic site, forming an extraordinarily stable, covalent phosphodiester bond. In some cases, the enzyme undergoes a secondary chemical transformation termed “aging” (the dealkylation of the organophosphate group), rendering the inhibition permanent.

The inhibition of acetylcholinesterase causes catastrophic systemic accumulation of acetylcholine at all cholinergic synapses throughout the organism. The result is the clinical emergency known as cholinergic crisis: overwhelming muscarinic hyperstimulation (profuse salivation, lacrimation, urination, defecation, gastrointestinal distress, emesis, bronchoconstriction, and bronchorrhea) combined with overwhelming nicotinic hyperstimulation at the neuromuscular junction, producing widespread fasciculations, followed by sustained depolarizing blockade and flaccid respiratory paralysis. Treatment requires the prompt administration of high-dose atropine to block the fatal muscarinic actions, combined with pralidoxime (2-PAM)—a nucleophilic oxime engineered to bind the inhibited enzyme, break the organophosphate-serine bond, and regenerate the active acetylcholinesterase before aging occurs.

Natural evolution has similarly targeted every node of Dale’s neuromuscular machinery. On the presynaptic side, botulinum neurotoxin, produced by the anaerobic bacterium Clostridium botulinum, is the most lethal biological substance known. Botulinum toxin enters the presynaptic motor nerve terminal via receptor-mediated endocytosis, where its light chain operates as a zinc-dependent endopeptidase that selectively cleaves the SNARE complex proteins (SNAP-25, syntaxin, or synaptobrevin) responsible for synaptic vesicle docking and fusion. The cleavage of these SNARE proteins completely arrests the exocytosis of acetylcholine, producing the flaccid paralysis of botulism. Conversely, alpha-latrotoxin, found in the venom of the black widow spider (Latrodectus), binds presynaptic neurexins and CIRL receptors, forming unregulated calcium-permeable membrane pores that trigger an uncontrolled, massive evacuation of all presynaptic acetylcholine stores, producing violent muscular spasms followed by transmission failure.

12. Conclusion: The Enduring Epistemological Legacy of Henry Dale

The experiments executed by Henry Hallett Dale, Wilhelm Feldberg, and Marthe Vogt between 1934 and 1936 were not merely an empirical victory over the electrical hypothesis of neuromuscular transmission. More profoundly, they established the methodological and philosophical standards that defined the twentieth-century biological sciences, transforming synaptic physiology from speculative biophysical deduction into a rigorous physical and chemical discipline.

12.1 Methodological Standards in Synaptic Physiology

Dale’s investigation established the classical evidentiary criteria that remain the universal benchmark for validating an authentic neurotransmitter in molecular neuroscience. Modern neurophysiologists continue to adhere to the classical criteria derived directly from Dale’s 1936 architecture:

• Presence and Synthesis: The chemical agent must be shown to be present within the presynaptic terminal, along with the biosynthetic enzymes, metabolic substrates, and transport systems required for its production.
• Stimulus-Evoked Release: The substance must be recovered from the extracellular environment specifically in response to physiological electrical stimulation of the presynaptic pathway, in a manner strictly dependent upon presynaptic depolarization and extracellular calcium influx.
• Pharmacological and Physiological Mimicry: The direct exogenous application of the candidate substance to the post-junctional membrane must replicate the precise electrical, mechanical, and ionic conductance changes provoked by natural nerve stimulation.
• Identity of Antagonism and Potentiation: Pharmacological agents that selectively potentiate, prolong, or block the biological action of the naturally evoked response must exert an identical quantitative effect on the response evoked by the exogenous candidate molecule.
• Inactivation Mechanism: An active, efficient, and localized mechanism—either enzymatic degradation or specialized high-affinity transmembrane re-uptake—must exist to rapidly terminate the biological action of the chemical within physiological timescales.

Dale demonstrated the necessity of combining disparate disciplines—pharmacology, biochemistry, surgical microdissection, and electrophysiology—to solve complex biological problems. His insistence upon rigorous negative controls, such as the demonstration that contracting denervated muscle yielded no chemical release and that curarized muscle continued to release acetylcholine, remains a model of experimental design.

12.2 The Evolution of Neurotransmission Paradigms

The vindication of chemical transmission at the somatic neuromuscular junction provided the conceptual foundation for the expansion of neurochemistry into the central nervous system. In the decades following the Second World War, the principles Dale established for the motor endplate were extended to the billions of synapses traversing the mammalian brain. Neuroscientists discovered that while acetylcholine operates as an excitatory transmitter at the neuromuscular junction and at diverse central loci, the central nervous system utilizes a vast array of chemical transmitters:

• Amino Acid Transmitters: Such as L-glutamate (the primary fast excitatory transmitter of the brain) and GABA (gamma-aminobutyric acid) alongside glycine (the primary fast inhibitory transmitters).
• Biogenic Amines: Including dopamine, norepinephrine, serotonin, and histamine, which operate primarily as diffuse modulators of neural circuits, emotion, and behavior.
• Neuropeptides: Such as substance P, neuropeptide Y, and endogenous opioids, which mediate complex, slow, and long-lasting synaptic adjustments.
• Atypical and Retrograde Messengers: Including gasotransmitters such as nitric oxide (NO) and carbon monoxide (CO), which diffuse retrogradely across membranes without vesicular packaging, as well as lipid-derived endocannabinoids (such as anandamide and 2-AG).

Despite this chemical complexity, the core biophysical insight pioneered by Dale remains untouched: the synapse is fundamentally a chemical-receptive gateway that transforms electrical impulses into discrete molecular signals, allowing the nervous system to achieve dynamic plasticity, computational integration, and fine-tuned modulation.

12.3 Retrospective Assessment of Dale’s Scientific Ethos

Beyond his experimental achievements, Henry Hallett Dale embodied an ideal of scientific integrity, philosophical modesty, and leadership. As the Director of the National Institute for Medical Research and later as President of the Royal Society, Dale steered scientific enterprise with a commitment to empirical truth over dogmatic entrenchment. He resisted the temptation to over-extend conclusions beyond the limits of his empirical data, famously maintaining that theories were merely working scaffolds to be demolished and rebuilt as fresh facts emerged from the laboratory.

The 1936 experiments on chemical transmission at the neuromuscular junction remain one of the most intellectually compelling achievements in the annals of physiology. By demonstrating that the voluntary movements of the body—the contraction of a muscle, the articulation of a word, the movement of a hand—are orchestrated by the rapid release and destruction of a chemical ester across a microscopic gap, Dale, Feldberg, and Vogt bridged the historic divide between mind and matter, physics and chemistry. In doing so, they provided the molecular foundation upon which modern neurobiology, clinical neurology, and pharmacological therapeutics continue to build.

References

• Bernard, C. (1856). Analyse physiologique des propriétés des systèmes musculaire et nerveux au moyen du curare. Comptes Rendus de l’Académie des Sciences, 43, 825–829. https://gallica.bnf.fr/ark:/12148/bpt6k3000m/f829.item
• Brown, G. L., Dale, H. H., & Feldberg, W. (1936). Reactions of the normal mammalian muscle to acetylcholine and to eserine. The Journal of Physiology, 87(4), 394–424. https://doi.org/10.1113/jphysiol.1936.sp003415
• Changeux, J. P., Kasai, M., & Lee, C. Y. (1970). Use of a snake venom toxin to characterize the cholinergic receptor protein. Proceedings of the National Academy of Sciences of the United States of America, 67(3), 1241–1247. https://doi.org/10.1073/pnas.67.3.1241
• Dale, H. H. (1914). The action of certain esters and ethers of choline, and their relation to muscarine. Journal of Pharmacology and Experimental Therapeutics, 6(2), 147–190. https://jpet.aspetjournals.org/content/6/2/147
• Dale, H. H. (1933). Nomenclature of fibres in the autonomic system and their chemical transmission. The Journal of Physiology, 80(3), 10P–11P. https://doi.org/10.1113/jphysiol.1933.sp003102
• Dale, H. H. (1935). Pharmacology and nerve-endings (Walter Ernest Dixon Memorial Lecture). Proceedings of the Royal Society of Medicine, 28(3), 319–332. https://doi.org/10.1177/003591573502800330
• Dale, H. H., & Dudley, H. W. (1929). The presence of histamine and acetylcholine in the spleen of the ox and the horse. The Journal of Physiology, 68(2), 97–123. https://doi.org/10.1113/jphysiol.1929.sp002598
• Dale, H. H., Feldberg, W., & Vogt, M. (1936). Release of acetylcholine at voluntary motor nerve endings. The Journal of Physiology, 86(4), 353–380. https://doi.org/10.1113/jphysiol.1936.sp003371
• du Bois-Reymond, E. (1877). Gesammelte Abhandlungen zur allgemeinen Muskel- und Nervenphysik (Vol. 2). Veit & Comp. https://archive.org/details/gesammelteabhan02boisgoog
• Eccles, J. C. (1946). An electrical hypothesis of synaptic and neuro-muscular transmission. Annals of the New York Academy of Sciences, 47(4), 429–455. https://doi.org/10.1111/j.1749-6632.1946.tb31729.x
• Eccles, J. C. (1964). The Physiology of Synapses. Springer-Verlag. https://doi.org/10.1007/978-3-642-94869-5
• Eccles, J. C., Fatt, P., & Koketsu, K. (1954). Cholinergic and inhibitory synapses in a pathway from motor-axon collaterals to Renshaw cells. The Journal of Physiology, 126(3), 524–562. https://doi.org/10.1113/jphysiol.1954.sp005226
• Elliott, T. R. (1905). The action of adrenaline. The Journal of Physiology, 32(5–6), 401–467. https://doi.org/10.1113/jphysiol.1905.sp001093
• Fatt, P., & Katz, B. (1951). An analysis of the end-plate potential addressed with an intracellular electrode. The Journal of Physiology, 115(3), 320–370. https://doi.org/10.1113/jphysiol.1951.sp004675
• Fatt, P., & Katz, B. (1952). Spontaneous subthreshold activity at motor nerve endings. The Journal of Physiology, 117(1), 109–128. https://doi.org/10.1113/jphysiol.1952.sp004735
• Feldberg, W. (1977). The early history of synaptic and neuromuscular transmission by acetylcholine: Reminiscences. In The Pursuit of Nature: Informal Essays on the History of Physiology (pp. 65–88). Cambridge University Press. https://doi.org/10.1017/CBO9780511759970.004
• Griffith, H. R., & Johnson, G. E. (1942). The use of curare in general anesthesia. Anesthesiology, 3(4), 418–420. https://doi.org/10.1097/00000542-194207000-00006
• Hunt, R., & Taveau, R. de M. (1906). On the physiological action of certain cholin derivatives and new methods for detecting cholin. British Medical Journal, 2(2399), 1788–1791. https://doi.org/10.1136/bmj.2.2399.1788
• Katz, B. (1966). Nerve, Muscle, and Synapse. McGraw-Hill. https://archive.org/details/nervemusclesynap0000katz
• Langley, J. N. (1905). On the reaction of cells and of nerve-endings to certain poisons, chiefly as regards the reaction of striated muscle to nicotine and to curari. The Journal of Physiology, 33(4–5), 374–413. https://doi.org/10.1113/jphysiol.1905.sp001128
• Ling, G., & Gerard, R. W. (1949). The normal membrane potential of frog sartorius fibers. Journal of Cellular and Comparative Physiology, 34(3), 383–396. https://doi.org/10.1002/jcp.1030340304
• Loewi, O. (1921). Über humorale Übertragbarkeit der Herznervenwirkung. Pflügers Archiv für die gesamte Physiologie des Menschen und der Tiere, 189(1), 239–242. https://doi.org/10.1007/BF01738910
• Neher, E., & Sakmann, B. (1976). Single-channel currents recorded from membrane of denervated frog muscle fibres. Nature, 260(5554), 799–802. https://doi.org/10.1038/260799a0
• Palade, G. E. (1954). Electron microscope observations of interneuronal and neuromuscular synapses. The Anatomical Record, 118(2), 335–336. https://doi.org/10.1002/ar.1091180210
• Patrick, J., & Lindstrom, J. (1973). Autoimmune response to acetylcholine receptor. Science, 180(4088), 871–872. https://doi.org/10.1126/science.180.4088.871
• Tansey, E. M. (1991). From the niggle to the riddle: Henry Dale, Wilhelm Feldberg, and the chemical transmission of nerve impulses. Medical History, 35(3), 275–305. https://doi.org/10.1017/s0025727300053883
• Valenstein, E. S. (2005). The War of the Soups and the Sparks: The Discovery of Neurotransmitters and the Dispute Over How Nerves Communicate. Columbia University Press. https://doi.org/10.7312/vale13588
• Walker, M. B. (1934). Treatment of myasthenia gravis with physostigmine. The Lancet, 223(5779), 1200–1201. https://doi.org/10.1016/S0140-6736(00)43280-4